Novartis AG
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. Its Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, established, and cardiovascular, renal and metabolism medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has collaboration agreements with Pear Therapeutics; Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute; Science 37; Bill & Melinda Gates Foundation; Amgen; University of California, Berkeley; Bristol-Myers Squibb; Drugs for Neglected Diseases initiative (DNDi); and TScan Therapeutics. The company was founded in 1895 and is headquartered in Basel, Switzerland. Show More...
-
Website http://www.novartis.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 89.12 CHF
-
Last Updated 24-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD 4.26 3.7 3.79 3.7 4.13 7.29 2.8 3.25 5.38 5.06 5.25 Dividends USD 1.96 2.37 2.52 2.48 2.76 2.73 2.71 2.72 2.98 2.85 3.04 Payout Ratio % * 45.1 55.9 71.0 65.3 66.9 79.5 95.3 96.9 52.2 94.0 94.3 Shares Mil 2.301 2.413 2.445 2.479 2.47 2.438 2.4 2.371 2.344 2.319 2.307 Book Value Per Share * CHF 27.34 25.85 25.29 26.48 29.44 32.07 32.14 30.54 33.29 22.58 21.39 Free Cash Flow Per Share * CHF 4.75 4.65 4.31 3.58 3.72 3.88 3.68 4.22 4.41 4.55 Return on Assets % 8.95 7.57 7.86 7.33 8.11 13.84 5.13 5.85 9.05 8.89 9.3 Financial Leverage (Average) 1.95 1.78 1.8 1.7 1.77 1.71 1.74 1.79 1.85 2.13 2.42 Return on Equity % 16.24 14.12 14.09 12.79 14.07 24.06 8.84 10.34 16.51 17.5 24.75 Return on Invested Capital % 13.11 11.33 11.53 10.74 11.77 19.28 7.37 8.23 12.39 12.51 15.51 Interest Coverage 17.91 15.34 16.52 16.72 18.43 13.42 12.06 12.58 15.46 11.52 11.92 Current Ratio 1.08 1.04 1.16 1.16 1.39 0.96 1.12 1.21 1.2 1.04 0.74 Quick Ratio 0.73 0.75 0.86 0.83 0.89 0.67 0.81 0.88 0.91 0.77 0.44 Debt/Equity 0.23 0.21 0.2 0.15 0.2 0.21 0.24 0.31 0.29 0.4 0.5